Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.
- DOI
- 10.1016/s1474-4422(25)00036-5
- Published
- 2025 Apr
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-25-00036-5,
title = {Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.},
author = {Awad IA and Alcazar-Felix RJ and Stadnik A and Kinkade S and Jhaveri A and Lee J and Hage S and Iqbal J and Polster SP and Shenkar R and Treine K and McBee N and Ostapkovich N and Lane K and Liao JK and Sorrentino M and Lee C and Flemming KD and Girard R and Carroll TJ and Thompson RE and Hanley DF},
year = {2025},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(25)00036-5},
url = {https://doi.org/10.1016/s1474-4422(25)00036-5}
}RIS
TY - JOUR TI - Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. AU - Awad IA AU - Alcazar-Felix RJ AU - Stadnik A AU - Kinkade S AU - Jhaveri A AU - Lee J AU - Hage S AU - Iqbal J AU - Polster SP AU - Shenkar R AU - Treine K AU - McBee N AU - Ostapkovich N AU - Lane K AU - Liao JK AU - Sorrentino M AU - Lee C AU - Flemming KD AU - Girard R AU - Carroll TJ AU - Thompson RE AU - Hanley DF PY - 2025 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(25)00036-5 UR - https://doi.org/10.1016/s1474-4422(25)00036-5 ER -
APA
IA, A., RJ, A., A, S., S, K., A, J., J, L., S, H., J, I., SP, P., R, S., K, T., N, M., N, O., K, L., JK, L., M, S., C, L., KD, F., R, G., TJ, C., RE, T., & DF, H. (2025). Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(25)00036-5
Source records
- pubmed · retrieved 2026-09-26T02:34:33.903Z